Fig. 2

All-cause and respiratory-related hospitalizations. Proportion of patients with a all-cause and c respiratory disease–related hospitalizations. Hospitalization rate per 6 months pre- and post-ALIS initiation for b all-cause and d respiratory disease-related hospitalizations (N = 331). The outcomes before and after ALIS initiation for the same patient population were compared. ALIS amikacin liposome inhalation suspension, ED emergency department. ^aHospitalizations include inpatient stays as well as hospital ED visits that lead to inpatient admission. ^bMcNemar’s Χ² test. ^cWilcoxon signed rank test